Suppression or Inhibition of VEGFs on Splenic Angiosarcoma Cell with Traditional Chinese Medicine Zhi Gan Cao
Stud Health Technol Inform. 2023 Nov 23;308:396-403. doi: 10.3233/SHTI230865.ABSTRACTPrimary splenic angiosarcoma is a very rare disease that causes the development of malignant tumors in the vascular endothelium of the splenic sinuses. Moreover, the disease maintains a very low survival rate for patients to live over 5 years, which is relatively low when compared to another splenic cancer, splenic lymphomas. The treatment options for splenic angiosarcoma narrow down to surgical removal or radiation combined with chemotherapy, but both cost a lot, so discovering potential alternative treatments may eventually increase the ...
Source: Studies in Health Technology and Informatics - November 26, 2023 Category: Information Technology Authors: Tianyang Zhao Source Type: research
